Skip to main content

Month: September 2023

Corbion launches AlgaPrime™ DHA P3, addressing the demand for sustainable active nutrition in the pet food industry

DATE   September 26, 2023     Corbion launches AlgaPrime™ DHA P3, addressing the demand for sustainable active nutrition in the pet food industry AlgaPrime™ DHA P3 offers pet food manufacturers higher levels of DHA while reducing dependency on scarce traditional omega-3 sources. Corbion, the global market leader in algae-based feed ingredients, announced today the launch of its new AlgaPrime™ DHA P3, a high-performance omega-3 ingredient enabling pet food manufacturers to enhance the nutritional profile of their products and boost DHA levels reducing dependency on marine-based resources and positively impacting their carbon footprint. Produced via microalgae precision fermentation, AlgaPrime™ DHA P3 helps meet increasing consumer demand for more sustainable pet food ingredients, as nearly 70% of pet...

Continue reading

Digital Media Solutions, Inc. Announces Delisting From The New York Stock Exchange

Delisting does not affect the Company’s day to day business operations or its relationships with partners or employees DMS will continue as a public company The Company’s Class A common stock is expected to continue to trade on the over-the-counter marketsCLEARWATER, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) — Digital Media Solutions, Inc. (NYSE: DMS) (“DMS” or the “Company”) today announced that it will be delisted from the New York Stock Exchange (the “NYSE”). The Company’s delisting follows the NYSE’s determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the NYSE’s continued listing standard that requires listed companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. The Company’s delisting does not affect the...

Continue reading

Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution

– The 510(k) Clearance from the United States Food and Drug Administration (FDA) allows for the U.S. commercialization of FemaSeed®, an intratubal artificial insemination option designed to augment the natural fertilization process – – FemaSeed® is an innovative infertility treatment designed to deliver sperm directly to where conception occurs in a woman’s fallopian tube – ATLANTA, Sept. 25, 2023 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced it has received 510(k) Clearance from the United States Food and Drug Administration (FDA) for FemaSeed®, an innovative...

Continue reading

Pineapple Energy Announces Expansion to Florida

MINNETONKA, Minn., Sept. 25, 2023 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced that subsidiary SUNation Energy has expanded to Tampa and Central Florida. Nationally recognized for its outstanding customer service, SUNation will now serve Central Florida homeowners with solar installations, battery storage, and EV charging services in addition to SPAN Smart Electrical Panel installations. As a Tesla Powerwall Certified Installer, the SUNation team has helped hundreds of homeowners keep the lights on during power outages with their solar and storage installations, which will prove especially useful during the summer months when air conditioning use is the highest and when hurricane season is in full swing...

Continue reading

Mount Logan Capital Inc. Announces Transaction with Canaccord Genuity G Ventures Corp. will not Proceed

TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (NEO: MLC) (the “Company” or “Mount Logan”) announces that Canaccord Genuity G Ventures Corp. (“G-Corp”) has announced that the board of directors of G-Corp has determined that they do not believe that G-Corp will receive the regulatory approvals required to extend G-Corp’s permitted timeline to complete the proposed qualifying transaction with Mount Logan, the transaction will not be proceeding and G-Corp intends to wind-up in accordance with its articles and the policies of Cboe Canada, the new business name of the Neo Exchange Inc. About Mount Logan Capital Inc. Mount Logan Capital Inc. is an alternative asset management and insurance solutions company that is focused on public and private debt securities in the North American market and the reinsurance of annuity...

Continue reading

Inspirato Announces CEO Transition

Co-Founder Brent Handler to Step Down; Independent Director Eric Grosse Appointed Chief Executive Officer Effective September 25, 2023 DENVER, Sept. 25, 2023 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato”) (NASDAQ: ISPO), the innovative luxury travel subscription brand, today announced that Co-Founder and Chief Executive Officer (CEO), Brent Handler, has stepped down while remaining a member of the Board of Directors. Inspirato’s Board of Directors has appointed Eric Grosse to serve as CEO effective September 25, 2023. “Inspirato was founded with the ambitious mission of creating lasting memories for discerning travelers by delivering exceptional value, service and certainty,” said Handler. “I’m incredibly proud of all we’ve accomplished and the meaningful impact we’ve made on the lives of our valued members. As Inspirato’s...

Continue reading

Rogers Communications 3Q23 Investment Community Teleconference November 9, 2023 at 8:00 a.m. ET

TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) — Rogers Communications Inc. plans to release its third quarter 2023 financial results on Thursday, November 9, 2023, before North American financial markets open. The results will be distributed by newswire and posted at investors.rogers.com. Rogers’ management will host its quarterly teleconference with the investment community to discuss the results and outlook at 8:00 a.m. ET. To access the teleconference, the live webcast will be available on the Investor Relations section of Rogers’ website at investors.rogers.com. Alternatively, the teleconference can be accessed by dialing 416-915-3239 (1-800-319-4610 toll free for North America) at least ten minutes prior to the scheduled start time and requesting access to Rogers’ third quarter 2023 results teleconference. An archive of the presentation...

Continue reading

Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the grant of an inducement award to the Company’s newly appointed Chief Commercial and Strategy Officer, Caren Deardorf. In connection with Ms. Deardorf’s appointment, the Editas Medicine Board of Directors approved a stock option grant to Ms. Deardorf as an inducement material to Ms. Deardorf entering into employment with Editas Medicine in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option provides for the purchase of up to 123,350 shares of Editas Medicine common stock at a price of $8.00 per share, the closing price per share of Editas Medicine common stock as reported by Nasdaq on the date of grant, and vests over four years, with 25 percent of the shares vesting on...

Continue reading

New Pacific Metals Announces C$35 Million Bought Deal Financing

Not for Distribution in the United States or to U.S. Newswire Services VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) — New Pacific Metals Corp. (TSX: NUAG; NYSE American: NEWP) (“New Pacific” or the “Company”) announced today that it has entered into an agreement with Raymond James Ltd. and Eight Capital (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (together with the Co-Lead Underwriters, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 13,208,000 common shares of the Company (the “Common Shares”) at a price of C$2.65 per Common Share, for total gross proceeds of approximately C$35 million (the “Offering”). The Company will also grant to the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to 1,981,200...

Continue reading

New Pacific Metals Announces C$35 Million Bought Deal Financing

VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) — New Pacific Metals Corp. (TSX: NUAG; NYSE American: NEWP) (“New Pacific” or the “Company”) announced today that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 13,208,000 common shares of the Company (the “Common Shares”) at a price of C$2.65 per Common Share, for total gross proceeds of approximately C$35 million (the “Offering”). The Company will also grant to the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to 1,981,200 additional Common Shares (the “Over-Allotment Shares”). The Over-Allotment Option will be exercisable for a period of 30 days following closing. Silvercorp Metals Inc. (“Silvercorp”) has...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.